Necroptosis-IN-3

Cat. No. M31123

All AbMole products are for research use only, cannot be used for human consumption.

Size	Price	Availability
5mg	USD 115 USD115	In stock
10mg	USD 195 USD195	In stock
25mg	USD 390 USD390	In stock
50mg	USD 600 USD600	In stock
100mg	USD 950 USD950	In stock

Free Delivery on orders over USD 500 Bulk Inquiry?

Necroptosis-IN-3, an inhibitor of necroptosis, inhibits TNF-α-induced necroptosis and also inhibits 11β-HSD1.

Molecular Weight	223.33
Formula	C12H17NOS
CAS Number	547698-18-0
Form	Solid
Solubility (25°C)	DMSO 100 mg/mL
Storage	Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month

Related Apoptosis Products
Coenzyme Q0 Coenzyme Q0 (CoQ0) is a potent, oral active ubiquinone compound. Coenzyme Q0 induces apoptosis and autophagy, suppresses of HER-2/AKT/mTOR signaling to potentiate the apoptosis and autophagy mechanisms. Coenzyme Q0 regulates NFκB/AP-1 activation and enhances Nrf2 stabilization in attenuation of inflammation and redox imbalance.
C6 Ceramide C6 Ceramide (C6-Cer) is a short-chain, cell-permeable ceramide pathway activator with anticancer activity. C6 Ceramide-mediated miR-29b expression participates in the progression of multiple myeloma through suppressing the proliferation, migration and angiogenesis of endothelial cells by targeting Akt signal pathway.
DB2115 tertahydrochloride DB2115 tertahydrochloride is a potent inhibitor of myeloid master regulator PU.1. DB2115 tertahydrochloride has the potential for researching cancers, including hematologic cancers.
14-3-3η Protein inhibitor 1 14-3-3η Protein inhibitor 1 is a 14-3-3η protein inhibitor with a KD of 35 µM.
Deferoxamine Deferoxamine (Deferoxamine B) is an iron chelator (binds to Fe(III) and many other metal cations), is widely used to reduce iron accumulation and deposition in tissues. Deferoxamine upregulates HIF-1α levels with good antioxidant activity. Deferoxamine also shows anti-proliferative activity, can induce apoptosis and autophagy in cancer cells.

Catalog